43 related articles for article (PubMed ID: 8641367)
1. Amelioration of retroviral vector silencing in locus control region beta-globin-transgenic mice and transduced F9 embryonic cells.
Osborne CS; Pasceri P; Singal R; Sukonnik T; Ginder GD; Ellis J
J Virol; 1999 Jul; 73(7):5490-6. PubMed ID: 10364297
[TBL] [Abstract][Full Text] [Related]
2. Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector.
Dang Q; Auten J; Plavec I
J Virol; 2000 Mar; 74(6):2671-8. PubMed ID: 10684282
[TBL] [Abstract][Full Text] [Related]
3. Asynchronous transcriptional silencing of individual retroviral genomes in embryonic cells.
Schlesinger S; Meshorer E; Goff SP
Retrovirology; 2014 Apr; 11():31. PubMed ID: 24742368
[TBL] [Abstract][Full Text] [Related]
4. Continuous cell supply from Krt7-expressing hematopoietic stem cells during native hematopoiesis revealed by targeted in vivo gene transfer method.
Tajima Y; Ito K; Umino A; Wilkinson AC; Nakauchi H; Yamazaki S
Sci Rep; 2017 Jan; 7():40684. PubMed ID: 28098173
[TBL] [Abstract][Full Text] [Related]
5. Interactions between Retroviruses and the Host Cell Genome.
Poletti V; Mavilio F
Mol Ther Methods Clin Dev; 2018 Mar; 8():31-41. PubMed ID: 29159201
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells and retroviral infection.
Banerjee P; Crawford L; Samuelson E; Feuer G
Retrovirology; 2010 Feb; 7():8. PubMed ID: 20132553
[TBL] [Abstract][Full Text] [Related]
7. From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis.
Mulet-Lazaro R; Delwel R
Hemasphere; 2023 Nov; 7(11):e969. PubMed ID: 37953829
[TBL] [Abstract][Full Text] [Related]
8. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.
Baum C; Itoh K; Meyer J; Laker C; Ito Y; Ostertag W
J Virol; 1997 Sep; 71(9):6323-31. PubMed ID: 9261349
[TBL] [Abstract][Full Text] [Related]
9. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
Baum C; Eckert HG; Stockschläder M; Just U; Hegewisch-Becker S; Hildinger M; Uhde A; John J; Ostertag W
J Hematother; 1996 Aug; 5(4):323-9. PubMed ID: 8877707
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the haemopoietic system by murine retroviruses.
Mak TW; Bernstein A
Clin Haematol; 1984 Jun; 13(2):447-59. PubMed ID: 6088145
[No Abstract] [Full Text] [Related]
11. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
Baum C; Eckert HG; Stocking C; Ostertag W
Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
[TBL] [Abstract][Full Text] [Related]
12. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
13. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.
Hildinger M; Eckert HG; Schilz AJ; John J; Ostertag W; Baum C
Gene Ther; 1998 Nov; 5(11):1575-9. PubMed ID: 9930313
[TBL] [Abstract][Full Text] [Related]
14. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; KlingmĂĽller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
15. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
Ohnishi N; Itoh K; Itoh Y; Baum C; Higashitsuji H; Yamaguchi K; Tsuji T; Okanoue T; Fujita J
Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]